Mast Diagnostica GmbH

Mast Diagnostica GmbH specializes in in vitro diagnostic (IVD) reagents. These include transport media for Chlamydia samples, like the MASTAZYME Chlamydia Transport Medium, as well as screening assays for infectious and autoimmune diseases. Examples include tests for nuclear and extractable antigens (ENA), antinuclear antibodies (ANA), and double-stranded DNA (dsDNA), such as the MASTAZYME™ ENA Screen 7 and MASTAZYME™ dsDNA. These products are designed for laboratory use to aid in the detection and diagnosis of specific conditions.

Mast Diagnostica GmbH is headquartered in Germany. The company’s location in Germany aligns with its focus on producing IVD reagents that comply with European regulatory standards, including those applicable to in vitro diagnostics.

Mast Diagnostica GmbH’s devices are listed in the eudamed registry, which is the European database for medical devices. This registry is used to track devices that have been placed on the market within the European Economic Area (EEA), ensuring transparency and compliance with EU regulations.

Mast Diagnostica GmbH’s devices fall under Class A and IVD General classifications. Class A devices are typically considered low-risk, while IVD General refers to in vitro diagnostics that are not classified under specific risk categories but still require compliance with EU IVD Regulation (EU) 2017/746. These classifications help determine the regulatory requirements for their development, manufacturing, and market placement.